Are DTC Programs Treating a Symptom or Cause of High Drug Prices?
October 22, 2025Jesse Mendelsohn, executive vice president at Model N, discusses the broader issues impacting drug prices. Pharmaceutical Executive: What impact will TrumpRx and other DTC programs have on drug availability? Jesse Mendelsohn: To be clear, anything that expands access to pharmaceutical manufacturing and drugs is good. Even if this only gets several…